RSC Publishing


Publishing

 

Cover image for Highlights in Chemical Biology , select for current issue

Highlights in Chemical Biology

Chemical biology news and research from across RSC Publishing.



Probing protein aggregation


02 July 2009

In 2006 an estimated 26.6 million people worldwide had Alzheimer's disease and those numbers are expected to have quadrupled by the year 2050. Now scientists in the US have developed a probe to better understand protein aggregation processes linked to the disease.

Songi Han at the University of California, Santa Barbara, and co-workers made the nitroxide-based molecule, which can be attached to specific amino acid sites in a protein. 

A diseased neuron; a disintegrating microtubule; a tau protein clump

The tau hypothesis proposes that tangles of tau proteins lead to Alzheimer's disease

© National Institutes of Health (NIH)

"measuring interfacial and surface hydration dynamics provides us with a unique tool to map out interactions between species or the transport of protons and water across membranes"
Tangles of tau proteins, proteins which are abundant in neurons, are thought by many to give rise to Alzheimer's disease. Han and her colleagues attached their probe to a tau protein at position 322, which sees only moving water molecules within 5 Angstroms. The probe can be used to measure the water's local diffusion coefficient on the surface of a protein as the interaction between the unpaired electron of the probe's nitroxide group and a proton in water increases the probe's nuclear magnetic resonance signal. This allows the researchers to measure water surface dynamics at low concentration, making it a very sensitive tool. 

Han's team used the probe to follow tau protein aggregation on the molecular level. As Han explains, 'being able to measure interfacial and surface hydration dynamics provides us with a unique tool to map out interactions between species or the transport of protons and water across membranes.' Introducing the probe into amyloid fibre proteins, such as those formed by tangled tau proteins, could give a clearer picture of how the fibres form and lead to further insight into the proteins' structural characteristics. 

"The approach could offer structural insights into those parts of a protein directly involved in inter-protein binding events underpinning aggregation"
- Mark Wilson
Mark Wilson, an expert in protein aggregation, University of Wollongong, Australia agrees that 'the approach could offer structural insights into those parts of a protein directly involved in inter-protein binding events underpinning aggregation.' Han adds that understanding protein function in this way is 'key to understanding the building blocks and machinery of life, or the mechanism of failure.'

Paul Cooper

Enjoy this story? Spread the word using the 'tools' menu on the left or add a comment to the Chemistry World blog. 

Link to journal article

Site-specific dynamic nuclear polarization of hydration water as a generally applicable approach to monitor protein aggregation
Anna Pavlova, Evan R. McCarney, Dylan W. Peterson, Frederick W. Dahlquist, John Lew and Songi Han, Phys. Chem. Chem. Phys., 2009, 11, 6833
DOI: 10.1039/b906101k

Also of interest

Instant insight: Think outside the cell

Mark Wilson and Justin Yerbury at the University of Wollongong, Australia, examine proteins' extracellular activities.

Attacking Alzheimer's disease

Fresh hope in battling Alzheimer's disease with three-pronged attack

The chemistry of Alzheimers disease
Arvi Rauk, Chem. Soc. Rev., 2009, 38, 2698
DOI: 10.1039/b807980n

O-GlcNAc modification in diabetes and Alzheimer's disease
Wagner B. Dias and Gerald W. Hart, Mol. BioSyst., 2007, 3, 766
DOI: 10.1039/b704905f

Alterations of some membrane transport proteins in Alzheimer's disease: role of amyloid -peptide
Rukhsana Sultana and D. Allan Butterfield, Mol. BioSyst., 2008, 4, 36
DOI: 10.1039/b715278g

Metallo-complex activation of neuroprotective signalling pathways as a therapeutic treatment for Alzheimers disease
Laura Bica, Peter J. Crouch, Roberto Cappai and Anthony R. White, Mol. BioSyst., 2009, 5, 134
DOI: 10.1039/b816577g

Targeting neurological disease with RNAi
Paul Lingor and Mathias Bähr, Mol. BioSyst., 2007, 3, 773
DOI: 10.1039/b701169e